De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common γ-chain knockout mice

Journal of Virology

Volumn 80, Issue 21, 2006, Pages 10683-10691

  Miyazato, Paola ^a   Yasunaga, Jun Ichirou ^a   Taniguchi, Yuko ^a   Koyanagi, Yoshio ^a   Mitsuya, Hiroaki ^b   Matsuoka, Masao ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN GAMMA CHAIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DNA METHYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; SCID MOUSE; VIRUS LOAD;

ANIMALS; ANTI-RETROVIRAL AGENTS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DNA METHYLATION; DNA, VIRAL; GENES, PX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOLOGIC MEMORY; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 33750288527     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01009-06     Document Type: Article

References (65)

1. Akagi, T., I. Takeda, T. Oka, Y. Ohtsuki, S. Yano, and I. Miyoshi. 1985. Experimental infection of rabbits with human T-cell leukemia virus type I. Jpn. J. Cancer Res. 76:86-94.
2. I. J. Virol. 76:3493-3501.
3. Arnold, J., B. Yamamoto, M. Li, A. J. Phipps, I. Younis, M. D. Lairmore, and P. L. Green. 2006. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 107:3976-3982.
4. Banghara, C. R., and M. Osame. 2005. Cellular immune response to HTLV-1. Oncogene 24:6035-6046.
5. Collins, N. D., G. C. Newbound, B. Albrecht, J. L. Beard, L. Ratner, and M. D. Lairmore. 1998. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 91:4701-4707.
6. Datta, S., N. H. Kothari, and H. Fan. 2000. In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity. J. Virol. 74:8277-8285.
7. Debacq, C., J. M. Heraud, B. Asquith, C. Bangham, F. Merien, V. Moules, F. Mortreux, E. Wattel, A. Burny, R. Kettmann, M. Kazanji, and L. Willems. 2005. Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1. Oncogene 24:7514-7523.
8. Derse, D., S. A. Hill, P. A. Lloyd, H. Chung, and B. A. Morse. 2001. Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors. J. Virol. 75:8461-8468.
9. null mice: suppression by an inhibitor against NF-κB. J. Virol. 77:5286-5294.
10. Etoh, K., S. Tamiya, K. Yamaguchi, A. Okayama, H. Tsubouchi, T. Ideta, N. Mueller, K. Takatsuki, and M. Matsuoka. 1997. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 57:4862-4867.
11. Fan, N., J. Gavalchin, B. Paul, K. H. Wells, M. J. Lane, and B. J. Poiesz. 1992. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I. J. Clin. Microbiol. 30:905-910.
12. Feigal, E., E. Murphy, K. Vranizan, P. Bacchetti, R. Chaisson, J. E. Drummond, W. Blattner, M. McGrath, J. Greenspan, and A. Moss. 1991. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity. J. Infect. Dis. 164:36-42.
13. Feuer, G., J. A. Zack, W. J. Harrington, Jr., R. Valderama, J. D. Rosenblatt, W. Wachsman, S. M. Baird, and I. S. Chen. 1993. Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood 82:722-731.
14. Franchini, G., R. Fukumoto, and J. R. Fullen. 2003. T-cell control by human T-cell leukemia/lymphoma virus type 1. Int. J. Hematol. 78:280-296.
15. Furuta, R. A., K. Sugiura, S. Kawakita, T. Inada, S. Ikehara, T. Matsuda, and J. Fujisawa. 2002. Mouse model for the equilibration interaction between the host immune system and human T-cell leukemia virus type 1 gene expression. J. Virol. 76:2703-2713.
16. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
17. Grassmann, R., M. Aboud, and K. T. Jeang. 2005. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 24:5976-5985.
18. Hanon, E., S. Hall, G. P. Taylor, M. Saito, R. Davis, Y. Tanaka, K. Usuku, M. Osame, J. N. Weber, and C. R. Bangham. 2000. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95:1386-1392.
19. Hanon, E., J. C. Stinchcombe, M. Saito, B. E. Asquith, G. P. Taylor, Y. Tanaka, J. N. Weber, G. M. Griffiths, and C. R. Bangham. 2000. Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13:657-664.
20. Hill, S. A., P. A. Lloyd, S. McDonald, J. Wykoff, and D. Derse. 2003. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors. J. Infect. Dis. 188:424-427.
21. Hinuma, Y., Y. Gotoh, K. Sugamura, K. Nagata, T. Goto, M. Nakai, N. Kamada, T. Matsumoto, and K. Kinoshita. 1982. A retrovirus associated with human adult T-cell leukemia: in vitro activation. Gann 73:341-344.
22. II is required for viral infectivity in vivo. J. Virol. 80:3469-3476.
23. Igakura, T., J. C. Stinchcombe, P. K. Goon, G. P. Taylor, J. N. Weber, G. M. Griffiths, Y. Tanaka, M. Osame, and C. R. Bangham. 2003. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 299:1713-1716.
24. Imada, K., A. Takaori-Kondo, T. Akagi, K. Shimotohno, K. Sugamura, T. Hattori, H. Yamabe, M. Okuma, and T. Uchiyama, 1995. Tumorigenicity of human T-cell leukemia virus type 1-infected cell lines in severe combined immunodeficient mice and characterization of the cells proliferating in vivo. Blood 86:2350-2357.
25. Ito, M., H. Hiramatsu, K. Kobayashi, K. Suzue, M. Kawahata, K. Hioki, Y. Ueyama, Y. Koyanagi, K. Sugamura, K. Tsuji, T. Heike, and T. Nakahata. 2002. NOD/SCID/gamma(c) (null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100:3175-3182.
26. f protein. J. Virol. 75:6086-6094.
27. Kannagi, M., S. Harada, I. Maruyama, H. Inoko, H. Igarashi, G. Kuwasbima, S. Sato, M. Monta, M. Kidokoro, M. Sugimoto, et al. 1991. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3:761-767.
28. Kannagi, M., S. Matsushita, H. Shida, and S. Harada. 1994. Cytotoxic T cell response and expression of the target antigen in HTLV-I infection. Leukemia 8(Suppl. 1):S54-S59.
29. Kim, S. J., A. M. Nair, S. Fernandez, L. Mathes, and M. D. Lairmore. 2006. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 176:5463-5470.
30. Kinoshita, T., M. Shimoyama, K. Tobinai, M. Ito, S. Ito, S. Ikeda, K. Tajima, K. Shimotohno, and T. Sugimura. 1989, Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:5620-5624.
31. Koyanagi, Y., Y. Itoyama, N. Nakamura, K. Takamatsu, J. Kira, T. Iwamasa, I. Goto, and N. Yamamoto. 1993. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology 196:25-33.
32. Lairmore, M. D., L. Silverman, and L. Ratner. 2005. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24:6005-6015.
33. Li, H. C., R. J. Biggar, W. J. Miley, E. M. Maloney, B. Cranston, B. Hanchard, and M. Hisada. 2004. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J. Infect. Dis. 190:1275-1278.
34. Machuca, A., B. Rodes, and V. Soriano. 2001. The effect of antiretroviral therapy on HTLV infection. Virus Res. 78:93-100.
35. Manel, N., F. J. Kim, S. Kinet, N. Taylor, M. Sitbon, and J. L. Battini. 2003. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 115:449-459.
36. Matsuoka, M., and K. T. Jeang. 2005. Human T-cell leukemia virus type I at age 25: a progress report. Cancer Res. 65:4467-4470.
37. Matsushita, S., H. Mitsuya, M. S. Reitz, and S. Broder. 1987. Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I. J. Clin. Investig. 80:394-400.
38. Michael, B., A. M. Nair, H. Hiraragi, L. Shen, G. Feuer, K. Boris-Lawrie, and M. D. Lairmore. 2004. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 1:39.
39. Nagai, M., M. B. Brennan, J. A. Sakai, C. A. Mora, and S. Jacobson. 2001. CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98:1858-1861.
40. Nakata, H., K. Maeda, T. Miyakawa, S. Shibayama, M. Matsuo, Y. Takaoka, M. Ito, Y. Koyanagi, and H. Mitsuya. 2005. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model. J. Virol. 79:2087-2096.
41. Nicot, C., M. Dundr, J. M. Johnson, J. R. Fullen, N. Alonzo, R. Fukumoto, G. L. Princler, D. Derse, T. Misteli, and G. Franchini. 2004. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 10:197-201.
42. Okochi, K., and H. Sato. 1984. Transmission of ATLV (HTLV-I) through blood transfusion. Princess Takamatsu Symp. 15:129-135.
43. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i:1031-1032.
44. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
45. Popovic, M., P. S. Sarin, M. Robert-Gurroff, V. S. Kalyanaraman, D. Mann, J. Minowada, and R. C. Gallo. 1983. Isolation and transmission of human retrovirus (human T-cell leukemia virus). Science 219:856-859.
46. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64:5682-5687.
47. II is required for in vivo replication: evidence of in vivo reversion. J. Virol. 78:3837-3845.
48. Sugiyama, H., H. Doi, K. Yamaguchi, Y. Tsuji, T. Miyamoto, and S. Hino. 1986. Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J. Med. Virol. 20:253-260.
49. Tajima, K., S. Tominaga, and T. Suchi. 1986. Malignant lymphomas in Japan: epidemiological analysis on adult T-cell leukemia/lymphoma. Hematol. Oncol. 4:31-44.
50. Takatsuki, K. 2005. Discovery of adult T-cell leukemia. Retrovirology 2:16.
51. Takatsuki, K., T. Uchiyama, K. Sagawa, and J. Yodoi. 1977. Adult T cell leukemia in Japan, p. 73-77. In S. Seno, F. Takaku, and S. Irino (ed.), Topic in hematology. The 16th International Congress of Hematology. Excerpta Medica. Amsterdam, The Netherlands.
52. Takeda, S., M. Maeda, S. Morikawa, Y. Taniguchi, J. Yasunaga, K. Nosaka, Y. Tanaka, and M. Matsuoka. 2004. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 109:559-567.
53. Tanaka, G., A. Okayama, T. Watanabe, S. Aizawa, S. Stuver, N. Mueller, C. C. Hsieh, and H. Tsubouchi. 2005. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J. Infect. Dis. 191:1140-1147.
54. Taniguchi, Y., K. Nosaka, J. Yasunaga, M. Maeda, N. Mueller, A. Okayama, and M. Matsuoka. 2005. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2:64.
55. Tateno, M., N. Kondo, T. Itoh, T. Chubachi, T. Togashi, and T. Yoshiki, 1984. Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization. J. Exp. Med. 159:1105-1116.
56. Taylor, G. P., S. E. Hall, S. Navarrete, C. A. Michie, R. Davis, A. D. Witkover, M. Rossor, M. A. Nowak, P. Rudge, E. Matutes, C. R. Bangham, and J. N. Weber. 1999. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-Tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J. Virol. 73:10289-10295.
57. Uchiyama, T. 1997. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu. Rev. Immunol. 15:15-37.
58. Uchiyama, T., J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino. 1977. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481-492.
59. Xiong, Z., and P. W. Laird. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25:2532-2534.
60. Yahata, T., K. Ando, Y. Nakamura, Y. Ueyama, K. Shimamura, N. Tamaoki, S. Kato, and T. Hotta. 2002. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice. J. Immunol. 169:204-209.
61. Yamamoto, N., M. Okada, Y. Koyanagi, M. Kannagi, and Y. Hinuma. 1982. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 217:737-739.
62. Yasunaga, J., T. Sakai, K. Nosaka, K. Etoh, S. Tamiya, S. Koga, S. Mita, M. Uchino, H. Mitsuya, and M. Matsuoka. 2001. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 97:3177-3183.
63. Yoshida, M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19:475-496.
64. II regulates gene transcription by binding CREB binding protein/p300. J. Virol. 75:9885-9895.
65. Zhao, T. M., B. Hague, D. L. Caudell, R. M. Simpson, and T. J. Kindt. 2005. Quantification of HTLV-I proviral load in experimentally infected rabbits. Retrovirology 2:34.